Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by fairweather1on Feb 03, 2014 7:40pm
433 Views
Post# 22167896

future earnings

future earnings
I have done some DD on this company, and I realize the company's future ii based  on acceptance of their technologies by the medical establishment.  In the meantime, I believe book value is almost non-existent and the couple of analysts I have read about only expect a penny or two of positive earnings in the next year and a half (as far as I"ve seen a forecast).

So my question here is:  "can anyone point me to a link discussing the possible earnings scenarios if/when their products and technologies turn the corner.  I realize this is a high risk/reward situation, but I just haven't seen any specific numbers or ranges of numbers related to the markets their products address.

Clearly there is some institutional buying here, so that is great support.  I would just like to see what they are basing their interest on.

thanks in advance 
Bullboard Posts